Olaparib monotherapy for previously treated pancreatic cancer with DNA damage repair genetic alterations other than germline BRCA variants findings from 2 phase 2 nonrandomized clinical trials
Milind Javle, Einat Shacham-Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David Fogelman, Ben Boursi, Syeda Uruba, Ofer Margalit, Robert A. Wolff, Talia Golan
Dive into the research topics of 'Olaparib monotherapy for previously treated pancreatic cancer with DNA damage repair genetic alterations other than germline BRCA variants findings from 2 phase 2 nonrandomized clinical trials'. Together they form a unique fingerprint.